11-23 852

Board of Veterans' Appeals·Decided August 7, 2018·No. 11-23 852·Unpublished

Opinion

Citation Nr: 18124194 Decision Date: 08/07/18 Archive Date: 08/06/18

DOCKET NO. 11-23 852 DATE: August 7, 2018 ORDER 1. Entitlement to a disability rating in excess of 30 percent for bronchial asthma prior to October 21, 2015, is denied. 2. Entitlement to a disability rating in excess of 60 percent for bronchial asthma from October 21, 2015, and thereafter is denied. 3. Entitlement to a total disability rating based on individual unemployability due to a service-connected disability (TDIU) is denied. FINDINGS OF FACT 1. Prior to October 21, 2015, the evidence does not show that bronchial asthma manifested with an FEV-1 of 40-to 55-percent predicted, FEV-1/FVC of 40 to 55 percent or, at least monthly visits to a physician for required care of exacerbations or intermittent (at least three per year) courses of systemic (oral or parenteral) corticosteroids or that it caused an exceptional or unusual disability picture. 2. From October 21, 2015, the evidence does not show that bronchial asthma manifested with an FEV-1 of less than 40 percent predicted, or FEV-1/FVC of less than 40 percent, or more than one attack per week with episodes of respiratory failure, or; required daily use of systemic (oral or parenteral) high dose corticosteroids or immuno-suppressive medications or that it caused an exceptional or unusual disability picture. 3. The Veteran is not precluded from securing or following a substantially gainful occupation due to bronchial asthma. CONCLUSIONS OF LAW 1. The criteria for a disability rating in excess of 30 percent for bronchial asthma prior to October 21, 2015, have not been met. 38 U.S.C. §§ 1155, 5107(b); 38 C.F.R. §§ 3.102, 3.321, 4.1-4.3, 4.7, 4.97, Diagnostic Code 6602. 2. The criteria for a disability rating in excess of 60 percent for bronchial asthma from October 21, 2015, have not been met. 38 U.S.C. §§ 1155, 5107(b); 38 C.F.R. §§ 3.102, 3.321, 4.1-4.3, 4.7, 4.97, Diagnostic Code 6602. 3. The criteria for referral for a TDIU rating prior to October 21, 2015 or a TDIU rating as of October 21, 2015, have not been met. 38 U.S.C. §§ 1155, 5107(b); 38 C.F.R. §§ 3.102, 3.340, 3.341, 4.3, 4.16. REASONS AND BASES FOR FINDINGS AND CONCLUSIONS The Veteran had active duty from March 1971 to September 1972. In September 2014, the Board denied the claim for an increased disability evaluation for his asthma. The Veteran appealed the Board’s decision to the United States Court of Appeals for Veterans Claims (Court). In May 2015, the Court issued a Joint Motion for Remand (JMR) partially vacating and remanding the Board’s September 2014 decision. The JMR focused on the Board’s previous finding as to whether the Veteran’s symptomatology related to his asthma warranted referral for extraschedular consideration, but vacated the determinations the Board made regarding schedular and extraschedular ratings. In August 2015, the Board remanded the claim for an increased disability rating for asthma and for entitlement to a TDIU rating. In April 2016, the VA Regional Office (RO) increased the Veteran’s disability rating to 60 percent rating for bronchial asthma, effective October 21, 2015, and denied an evaluation in excess of 30 percent prior to that date. The RO also denied entitlement to a TDIU rating. In March 2017, the Board remanded the claims again for additional development and referred the matter to determine whether extraschedular consideration was warranted for the Veteran’s bronchial asthma. A more in-depth discussion of the procedural history concerning extraschedular consideration is within the extraschedular analysis set forth below. The matter has returned to the Board for a decision. The Board finds that the matter has been fully developed and adjudication is appropriate. Increased Disability Rating for Bronchial Asthma Disability ratings are determined by evaluating the extent to which a service-connected disability adversely affects the ability to function under the ordinary conditions of daily life, including employment, by comparing symptomatology with the criteria set forth in the Schedule for Rating Disabilities. See 38 U.S.C. § 1155, 38 C.F.R. § 4.1. A disability rating may require re-evaluation in accordance with changes in condition. Where a veteran is appealing the rating for an already established service-connected condition, the veteran’s present level of disability is of primary concern. See Francisco v. Brown, 7 Vet. App. 55, 58 (1994). Staged ratings are appropriate when the evidence establishes that the claimed disability manifested symptoms that would warrant different ratings for distinct time periods. See 38 C.F.R. § 4.71a. In this case, the Veteran has a staged rating. He has a 30 percent disability rating prior to October 21, 2015 and a 60 percent disability rating as of October 21, 2015. The Board’s analysis reviews closely both ratings and whether the evidence of record supports an increase for either disability rating for the Veteran’s asthma. When all the evidence is assembled, the Board is then responsible for determining whether the evidence supports the claim or is in relative equipoise, with the Veteran prevailing in either event, or whether the preponderance of the evidence is against the claim, in which case, the claim is denied. 38 U.S.C. § 5107; 38 C.F.R. § 3.102. The Veteran is service connected for bronchial asthma. Under the current Diagnostic Code 6602, pertaining to bronchial asthma, a 30 percent rating is assigned for FEV-1 of 56- to 70- percent predicted, or FEV-1/FVC of 56 to 70 percent or daily inhalational or oral bronchodilator therapy or inhalational anti-inflammatory medication. A 60 percent rating is assigned for an FEV-1 of 40-to 55- percent predicted, or FEV-1/FVC of 40 to 55 percent, or at least monthly visits to a physician for required care of exacerbations, or intermittent (at least 3 times per year) course of systemic (oral or parenteral) corticosteroids. A maximum 100 percent rating is assigned for bronchial asthma with an FEV-1 of less than 40-percent predicted, or FEV-1/FVC less than 40 percent, or more than 1 attack per week with episodes of respiratory failure, or requires daily use of systemic (oral or parenteral) high dose corticosteroids or immunosuppressive medications. 38 C.F.R. § 4.97, Diagnostic Code 6602. Generally, pulmonary function tests results are reported before and after the administration of bronchodilator therapy. VA regulations instruct that post-bronchodilator results be used when considering pulmonary function tests criteria for ratings under Diagnostic Codes 6600, 6603, 6604, 6825-6833, and 6840-6845. See 38 C.F.R. § 4.96(d)(4). There are no regulations identifying whether pre- or

Free access — add to your briefcase to read the full text and ask questions with AI

11-23 852, (bva 2018).

11-23 852 (11-23 852) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Jandreau v. Nicholson
492 F.3d 1372 (Federal Circuit, 2007)
Dennis M. Thun v. James B. Peake
22 Vet. App. 111 (Veterans Claims, 2008)
Rick K. Kahana v. Eric K. Shinseki
24 Vet. App. 428 (Veterans Claims, 2011)
Van Hoose v. Brown
4 Vet. App. 361 (Veterans Claims, 1993)
Hatlestad v. Brown
5 Vet. App. 524 (Veterans Claims, 1993)
Francisco v. Brown
7 Vet. App. 55 (Veterans Claims, 1994)
Jones v. Brown
7 Vet. App. 134 (Veterans Claims, 1994)